JPRN-UMIN000007292已完成未知
Effect of mosapride on glycemic control and incretin secretion - Effect of mosapride on incretin secretion
Yokohama City Unversity0 个研究点目标入组 40 人开始时间: 2012年2月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •taking another medicine to improve gastric movement
研究者
相似试验
进行中（未招募）
不适用
Effect of glimepiride on glycemic control in patients with typ 2 diabetes treated with insulin and metfromiPatients with type 2 diabetes, who are treated with insulin and metformin .EUCTR2008-001092-29-SEKarolinska Institutet, Department of Clinical Sciences, Danderyd Hospital. Division of internal medi
尚未招募
4 期
Effect of soya protein powder ALMASED on Diabetic patientsObesityCTRI/2011/11/002152Almased Wellness GmbH240
进行中（未招募）
不适用
Effekt av domperidon på p-glukosnivåerna och glukosvariabiliteten över dygnet hos personer med typ-1 diabetes.Diabetes mellitus typ 1MedDRA version: 12.0Level: LLTClassification code 10045228Term: Type I diabetes mellitusEUCTR2009-009436-69-SEDanderyds sjukhus AB
暂停
1 期
Effects of risperidone on glucose metabolism and gut microbiota in healthy adults: an open-label, pilot, randomized controlled trialHealthy adultsJPRN-jRCTs041210165Oshima Megumi24
进行中（未招募）
不适用
Effects of vildaglipitin and glimepiride on variability of glycemic values and cardiovascular risk in diabetic patients is not well controlled with insulin eveningEUCTR2013-002955-13-ITAFAR